CRIS Current Research Information System

GIORDANI, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.147
AS - Asia 4.778
EU - Europa 4.128
Continente sconosciuto - Info sul continente non disponibili 334
AF - Africa 330
SA - Sud America 235
OC - Oceania 16
Totale 14.968
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.988
IT - Italia 1.846
CN - Cina 1.295
SG - Singapore 1.236
VN - Vietnam 1.020
GB - Regno Unito 591
DE - Germania 403
HK - Hong Kong 391
SE - Svezia 240
IN - India 208
FR - Francia 203
BR - Brasile 175
NL - Olanda 174
KR - Corea 154
RU - Federazione Russa 143
BD - Bangladesh 127
CI - Costa d'Avorio 102
IE - Irlanda 98
CA - Canada 93
FI - Finlandia 92
UA - Ucraina 76
ZA - Sudafrica 71
JP - Giappone 70
TG - Togo 59
ID - Indonesia 44
CH - Svizzera 40
SC - Seychelles 35
BE - Belgio 34
TH - Thailandia 32
EE - Estonia 31
AR - Argentina 28
JO - Giordania 28
BG - Bulgaria 26
ES - Italia 25
PH - Filippine 22
TR - Turchia 22
NG - Nigeria 21
MX - Messico 20
IQ - Iraq 19
PL - Polonia 19
IR - Iran 18
PK - Pakistan 18
AT - Austria 17
TW - Taiwan 16
AU - Australia 12
MY - Malesia 11
UZ - Uzbekistan 10
CZ - Repubblica Ceca 9
EG - Egitto 9
GR - Grecia 9
HR - Croazia 9
JM - Giamaica 9
NO - Norvegia 9
CL - Cile 8
EC - Ecuador 8
TN - Tunisia 8
RO - Romania 6
SA - Arabia Saudita 6
BB - Barbados 5
CO - Colombia 5
DK - Danimarca 5
DZ - Algeria 5
IL - Israele 5
KE - Kenya 5
LB - Libano 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
MA - Marocco 4
NZ - Nuova Zelanda 4
OM - Oman 4
PR - Porto Rico 4
SI - Slovenia 4
UY - Uruguay 4
AL - Albania 3
GT - Guatemala 3
HU - Ungheria 3
KZ - Kazakistan 3
NI - Nicaragua 3
PE - Perù 3
SN - Senegal 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BZ - Belize 2
ET - Etiopia 2
HN - Honduras 2
KW - Kuwait 2
LT - Lituania 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AM - Armenia 1
AO - Angola 1
Totale 14.621
Salva come PNG Salva come JPEG
Città #
Singapore 839
Ashburn 586
Southend 465
Hong Kong 357
San Jose 342
Bologna 338
Hefei 302
Chandler 245
Ho Chi Minh City 225
Hanoi 221
Dallas 208
Santa Clara 191
Ann Arbor 167
Council Bluffs 161
Los Angeles 158
New York 155
Seoul 141
Beijing 134
Frankfurt am Main 126
Fairfield 117
Boardman 109
Milan 104
Abidjan 102
Princeton 102
Dong Ket 97
Dublin 95
Houston 92
Seattle 85
Wilmington 82
Rome 76
Helsinki 64
Lauterbourg 64
Lomé 59
Turin 55
Woodbridge 53
Cambridge 52
Nanjing 49
Tokyo 49
Padova 48
Shanghai 43
Berlin 42
Redmond 42
Westminster 42
Buffalo 41
Guangzhou 40
San Francisco 39
Orem 35
Chicago 34
Atlanta 33
Medford 33
Naples 33
Dearborn 32
Denver 32
Tukwila 32
Haiphong 30
Montreal 30
Bengaluru 29
Da Nang 29
Munich 29
Amman 28
Brooklyn 28
Jinan 28
Toronto 28
São Paulo 27
London 25
Phoenix 25
Redondo Beach 25
Sofia 25
Basingstoke 24
Jakarta 24
Tianjin 24
Bern 22
Florence 22
Shenyang 22
Abeokuta 21
Brussels 21
Johannesburg 20
Redwood City 20
Rimini 20
The Dalles 20
Nanchang 19
Changsha 18
Catania 17
Genoa 17
Modena 17
Saint Petersburg 17
Verona 17
Zhengzhou 17
Boston 16
Cesena 16
Biên Hòa 15
Amsterdam 14
Bangkok 14
Forlì 14
Lappeenranta 14
Cagliari 13
Boydton 12
Des Moines 12
Hebei 12
Falkenstein 11
Totale 8.416
Salva come PNG Salva come JPEG
Nome #
Accuratezza della spettrometria di massa MALDI-TOF nell’identificazione di specie di lattobacilli 766
Lactobacillus Biofilms Influence Anti-Candida Activity 748
NUOVI APPROCCI PER L’IDENTIFICAZIONE DI SPECIE DI LATTOBACILLI: RUOLO DELLA SPETTROMETRIA DI MASSA MALDI-TOF E DELLA METABOLOMICA 507
BIFIDOBACTERIUM BREVE BC104: ORALLY ADMINISTERED VAGINAL PROBIOTIC FOR PREVENTING GENITAL AND URINARY TRACT INFECTIONS 418
Dairy bioactives and functional ingredients with skin health benefits 340
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells. 295
Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis 289
Antioxidant and Functional Features of Pre-Fermented Ingredients Obtained by the Fermentation of Milling By-Products 260
Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion 254
Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models 246
Vaginal Lactobacillus gasseri biosurfactant: a novel bio- and eco-compatible anti-Candida agent 238
Liposomes containing biosurfactants isolated from Lactobacillus gasseri exert antibiofilm activity against methicillin resistant Staphylococcus aureus strains 226
Lactobacilli extracellular vesicles: potential postbiotics to support the vaginal microbiota homeostasis 225
Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms 222
Design and validation of a DNA-microarray for phylogenetic analysis of bacterial communities in different oral samples and dental implants 222
Biosurfactant for solubilization and skin permeation enhancement of hydrocortisone 216
Anti-bacterial activity of vaginal lactobacilli against Chlamydia trachomatis 213
Lactobacilli cell-free supernatants: Potential green and natural enhancers for nose-to-brain delivery of small hydrophilic molecules 208
Biotechnological Valorization of Brewer's Spent Grains and Grape Pomace to Obtain Functional Ingredients for Food Formulations 207
Novel approaches for the taxonomic and metabolic characterization of lactobacilli: Integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 205
Orange Peel Lactiplantibacillus plantarum: Development of A Mucoadhesive Nasal Spray with Antimicrobial and Anti-Inflammatory Activity 205
Novel mixed vesicles containing lactobacilli biosurfactants for vaginal delivery of econazole nitrate 201
OralArray: a new phylogenetic DNA-microarray to characterize the oral microbiota 199
Anti-candida activity of hyaluronic acid combined with lactobacillus crispatus lyophilised supernatant: A new antifungal strategy 194
Vaginal Lactobacillus strains interfere with Chlamydia trachomatis infection 193
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections 190
Vaginal Lactobacillus Impair Candida Dimorphic Switching and Biofilm Formation 187
Association of mucoadhesive polymeric matrices and liposomes for local delivery of miconazole: A new approach for the treatment of oral candidiasis 186
Studio in vitro dell’attività antimicrobica di lattobacilli vaginali nei confronti di Chlamydia trachomatis. 185
Lecithin and Chitosan as Building Blocks in Anti-Candida Clotrimazole Nanoparticles 181
Limosilactobacillus vaginalis Exerts Bifidogenic Effects: A Novel Postbiotic Strategy for Infant Prebiotic Supplementation 174
Approcci innovativi per l’identificazione di specie di lattobacilli: studio dei metaboliti mediante spettrometria di risonanza magnetica (1H-RMN) 173
Isolation and characterization of biosurfactants produced by Lactobacillus gasseri of vaginal origin 171
Ondansetron Buccal Administration for Paediatric Use: A Comparison Between Films and Wafers 170
Biosurfactant loaded vesicles for the local treatment of Staphylococcus aureus skin infections 168
Mucoadhesive and mucopenetrating chitosan nanoparticles for glycopeptide antibiotic administration 166
Functional and biochemical characterization of pre-fermented ingredients obtained by the fermentation of durum wheat by-products 164
Vaginal Bifidobacterium breve for preventing urogenital infections: Development of delayed release mucoadhesive oral tablets 158
Lactobacillus crispatus BC1 Biosurfactant Delivered by Hyalurosomes: An Advanced Strategy to Counteract Candida Biofilm 158
THE HEALTH-PROMOTING EFFECT OF EXTRACELLULAR VESICLES RELEASED BY VAGINAL LACTOBACILLI 152
Development and validation of a new phylogenetic DNA-microarray specific for the oral microbiota 152
The vaginal microbiome of healthy, bacterial vaginosis and Chlamydia trachomatis-infected women 148
Freeze-Dried Matrices Based on Polyanion Polymers for Chlorhexidine Local Release in the Buccal and Vaginal Cavities 148
Interaction of vaginal Lactobacillus strains with HeLa cell plasma membrane. 147
Utilizing liposomal quercetin and gallic acid in localized treatment of vaginal Candida infections 144
Prebiotic Activity of Vaginal Lactobacilli on Bifidobacteria: from Concept to Formulation 142
Lactobacillus strains isolated from vaginal microbiota of healthy women inhibit Candida growth and adherence 140
Lactobacilli cell-free supernatants can improve cromolyn nasal absorption 139
Effect of Lactobacillus biosurfactant on hydrocortisone solubilization and skin permeation 138
New Spanish Broom dressings based on Vitamin E and Lactobacillus plantarum for superficial skin wounds 137
Role of vaginal lactobacilli in counteracting Chlamydia trachomatis infectivity in an in vitro model 136
Lactobacillus crispatus BC1 Biosurfactant Counteracts the Infectivity of Chlamydia trachomatis Elementary Bodies 136
Novel approaches for the species-level identification of lactobacilli: integration of 16S rRNA gene sequencing with MALDI-TOF MS and 1H-NMR 134
Influence of lactobacillus biosurfactants on skin permeation of hydrocortisone 133
Characterization of anti-Candida activity of vaginal lactobacilli 128
Biosurfactant-based mixed vesicles for vaginal delivery of econazole 128
Interaction of vaginal Lactobacillus strains with HeLa cells plasma membrane 126
Vaginal lactobacilli exert prebioTIc effects towards gut bifidobacteria 123
Development of chitosan nanoparticles with mucoadhesive/mucopenetrating properties 121
Functional and Safety Profile of Limosilactobacillus vaginalis and Development of Oral Fast-Disintegrating Tablets for Gut Microbiota Modulation 119
Preliminary results on the preparation of Spanish Broom, flax and hemp wound dressings based on 18-β-glycyrrhetinic acid-cyclodextrin inclusion complexes 117
Orally administered vaginal Bifidobacterium Breve BC104 for preventing genital and urinary tract infections 116
A new wound dressing based on Spanish Broom fibers for the local release of Vitamin E and Lactobacillus plantarum 116
Human Lactobacillus Biosurfactants as Natural Excipients for Nasal Drug Delivery of Hydrocortisone 111
New liposomes containing natural molecules for treatment of vaginal diseases 109
Exopolysaccharides released by vaginal Lactobacillus strains: chemical characterization and modulation of biofilm formation. 108
Freeze-dried matrices for chlorhexidine release in the buccal and vaginal cavities 108
Impact of Lactobacillus exopolysaccharides on vaginal microbial biofilms 104
Lactobacillus biosurfactant as natural excipient for nasal drug delivery 101
New Spanish Broom’s wound dressing loaded with Vitamin E and Lactobacillus plantarum for skin wounds 97
null 96
Lactobacillus biosurfactant: a green excipient for the preparation of vaginal mixed vesicles 95
null 94
Novel mixed vesicles containing lactobacilli biosurfactant for vaginal delivery of an anti-Candida agent 93
Sistemi gelificanti in situ per la veicolazione intranasale e naso-cervello di farmaci con diverse proprietà fisico-chimiche 92
The vaginal microbiome of healthy, bacterial vaginosis and Chlamydia trachomatis-infected women 90
Vaginal Lactobacilli interfere with Chlamydia trachomatis infection process in HeLa cells. 88
Candida spp. biofilm formation is inhibited by vaginal Lactobacillus supernatants 86
Tailored anti-biofilm activity - Liposomal delivery for mimic of small antimicrobial peptide 82
LACTOBACILLUS VAGINALIS BC17 DERIVATIVES EXERT BIFIDOGENIC ACTIVITY 80
Lactobacilli as Anti-biofilm Strategy in Oral Infectious Diseases: A Mini-Review 77
Liposomes-in-chitosan hydrogel boosts potential of chlorhexidine in biofilm eradication in vitro 71
Biotechnological valorization of brewer's spent grains through microbial fermentation and High-Pressure Homogenization (HPH) treatments to obtain functional ingredients for food formulations 68
Microbial fermentation and high-pressure homogenization as integrated strategies for the valorization of brewer’s spent grains into functional food ingredients 64
Nanocarriers for the delivery of Lactobacillus crispatus BC1 biosurfactant: alternative strategies to fight Candida biofilms 59
null 47
Totale 14.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.936
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.936
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022939 0 57 55 27 103 57 39 75 46 82 215 183
2022/20231.483 137 185 79 177 111 106 29 87 256 104 105 107
2023/2024911 57 73 64 98 92 174 60 72 42 64 59 56
2024/20252.543 122 228 237 186 318 120 316 146 62 164 193 451
2025/20266.274 429 595 527 430 474 257 817 184 887 436 935 303
2026/2027595 338 257 0 0 0 0 0 0 0 0 0 0
Totale 14.968